CRISPRmod CRISPRa dCas9-VPR

The Horizon CRISPRmod CRISPR activation (CRISPRa) system is an adapted CRISPR-Cas9 system that is used for upregulation of genes. It utilizes a nuclease-deactivated S. pyogenes Cas9 (dCas9), that is fused to transcriptional activation domains (VP64, p65 and Rta). When paired with guide RNAs that target a gene near a promoter region, the gene's native transcription start site is activated.

There are several format options for dCas9-VPR. The dCas9-VPR mRNA allows for direct co-transfection or electroporation of reagents and provides options for enrichment by fluorescence or antibiotic selection. Lentiviral dCas9-VPR reagents can be used to generate a stable population of dCas9-VPR cells which is ideal for screening and for extended timepoint assays. Lentiviral dCas9-VPR reagents are available with three different promoters (hCMV, mCMV, or hEF1a) and can be supplied as either purified high-titer lentiviral particles or purified plasmid DNA.

 

CRISPRa for gene activation

CRISPR-Cas9 is not only for creating genomic double-strand breaks, it can also be used to target promoter regions to activate or inhibit transcription. Using a deactivated or dead Cas9 nuclease fused to transcription activators, like Cas9-VPR, in combination with a guide RNA in either a synthetic sgRNA or crRNA or lentiviral format, the endogenous expression of a gene can be up-regulated by anywhere from 5 to 50,000+ fold!

 

dCas9-VPR reagents for optimization and enrichment

Enrichment for gene activation can now easily be done using the dCas9-VPR mRNA reagents that co-express either EGFP or puromycin with dCas9-VPR. These reagents allow easy co-transfection or electroporation for optimization and visualization of successful delivery.

 

Choose from a variety of dCas9-VPR vectors

Promoter activity will vary by cell type and will affect dCas9-VPR expression, choosing an optimal promoter is important for robust gene overexpression. Lentiviral dCas9-VPR reagents are available with three different promoters (hCMV, mCMV, or hEF1a) and can be supplied as either purified high-titer lentiviral particles or purified plasmid DNA.

Table 1. SMARTchoice promoter options for expressing dCas9-VPR nuclease
Promoter Description
hCMV human cytomegalovirus immediate early promoter
mCMV mouse cytomegalovirus immediate early promoter
hEF1α human elongation factor 1 alpha promoter